Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
Public Health|December 25, 2021
Incidence of infectious diseases after earthquakes: a systematic review and meta-analysisSara Najafi, Arash Akahavan Rezayat, Seyyedeh Faezeh Beyzaei, et al.
Phytotherapy Research : PTR|May 6, 2021
A randomized, double-blind, placebo-controlled, clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patientsParisa Shoaei-Hagh, Farzaneh Kamelan Kafi, Sara Najafi, et al.
Cells|April 30, 2021
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in NeuroblastomaKatharina Körholz, Johannes Ridinger, Damir Krunic, et al.
Pharmaceuticals (Basel, Switzerland)|October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish XenograftsJagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Leukemia|September 19, 2024
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteinsMelisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor CellsRamy Ashry, Mohamed Abdelsalam, Julia Hausen, et al.
BMC Public Health|January 5, 2023
Effective factors of improved helmet use in motorcyclists: a systematic reviewPouya Mahdavi Sharif, Sara Najafi Pazooki, Zahra Ghodsi, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Cell Death and Differentiation|March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatmentJing Shen, Sara Najafi, Sina Stäble, et al.
Pageof 3